San Francisco, California, February 15, 2018: The global market for implantable ports is expected to surge forward in the coming years on account of the efforts of the healthcare industry to devise better treatment mechanisms. Implantable ports are plastic tubes that are used to administer drugs inside the body. They are soft, narrow, and long with a rubber disc fitted at one end which helps in effective discharge of the drugs into the body. The most popular usage of these ports is in administering drugs essential for chemotherapy. Subcutaneous is another name for implantable ports that range from 2.5-4 cm in diameter. The discharge of drugs or other chemicals into the veins takes place with the use of these tubes, which spurs their popularity across several domains within healthcare. Some of the key uses of these tubes include blood transfusions, discharge of intravenous fluids and antibiotics, and chemotherapy. The growth of cardiovascular diseases necessitates the need for implantable ports that can ease the entire process of drug administration. The concerns regarding the growing toll of cancers has also made it imperative for the healthcare industry to extensively adopt these tubes. A report by TMR sheds light on several dynamics that play an integral role in deciding the fate of the market. The report titled ‘Implantable Ports Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025’ mentions key parameters such as growth rate, market value, and regional market share in order to give a holster view of the market.
The alarming statistics with regards to cancer have created a sense of awakening across the world for better treatment facilities. The increasing pressure on the healthcare industry to attenuate the severity of cancers has persuaded them have all the devices and infrastructure. The estimates of the International Agency for Research in Cancer (IARC) point that the number of new cancer cases in the coming years is expected to reach 21.7 million. The aforementioned factors play a vital role in enhancing demand for implantable ports. Furthermore, the rising disposable income has made treatments such as chemotherapy more affordable for the populace. This is also expected to boost the demand within the market. The advancements in technology have given a boost to the effectiveness of these ports as the market players engage in developing safer products. Coated or impregnated technology does not need transient materials anymore which also playing to the advantage of the market.
Despite the affluence of the global market for implanted tubes, the safety issues with regards to the usage of these tubes still haunts the market players. The risk of side effects such as clots, blockages, and infections has also been a major hindrance for the growth of the market. The presence of alternatives such as peripherally inserted central catheters (PICCs) and peripheral IV catheters (PIVCs) is also a hurdle in the way of market players. Nevertheless, the popularity of disposable implantable ports and titanium based implants is expected to keep bolstering the market. Moreover, safety guidelines that have been established with regards to the usage of these ports also offers assistance to the market.
Geographically, North America is anticipated to emerge as the most successful region due to the prominence of its healthcare infrastructure. The growing geriatric population across the U.S. is also an important standpoint for market growth in the region. Europe and Asia Pacific is also expected to exhibit lucrative growth patterns over the coming years.
The leading market players are expected to invest in safety, ease of usage, and marketing in order to outdo competition. Some of these key players include C.R. Bard, Teleflex, B. Braun Melsungen, Smiths Medical, and AngioDynamics.
Get Sample Copy of this Report